Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of hydrogen sulfide synthesis inhibitors for cancer therapy

Use of hydrogen sulfide synthesis inhibitors for cancer therapy

US Patent 10335382 · Granted Jul 2, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for treating cancer2025
Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(2024
Fendiline derivatives2024
Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists2023
Compounds and methods for inhibiting viral replication and methods of treating a2023
Pharmaceutical compositions and methods of use for activation of human fibroblas2023
Polymer dispersions for wax inhibition during stimulation treatment2023
Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(2022
BRD4 inhibitor treatment of IgE-mediated diseases2022
Compounds and methods for treating cancer2022
EPAC antagonists2021
Inhibitors of bromodomain-containing protein 4 (BRD4)2021